Unyvero
Unyvero Lower Respiratory
Unyvero Urinary Tract
Unyvero System
Unyvero Resources
Product Literature
Publications
Videos
Webinars
Instructions for Use
Safety Data Sheets
Unyvero Global
Ares
ARES Products
ARES
cloud
ARES
db
ARES Services
ARES
iss
ARES
id
ARES
asp
ARES
Bioinformatics
ARES Newsletter
ARES Resources
Product Literature
Publications
Webinars
About Ares Genetics
ARES Leadership
ARES Global Network
Contact ARES
Acuitas
Acuitas AMR Gene Panel
Acuitas Resources
Product Literature
Publications
Webinars
Package Inserts
Electronic User Guide
Safety Data Sheets
Resources
All Resources
Publications
Videos
Webinars
Request Demo
Contact Us
About
Overview
Management Team
Board of Directors
Clinical Advisory Board
Careers
News & Events
Press Releases
OpGen In The News
Corporate Videos
Conferences
Investors
Stock Information
News & Events
SEC Filings
Investor FAQ
Corporate Governance
Financial Information
Shareholder Services
Contact Us
Acuitas Lighthouse Login
OpGen In The News
OpGen announces positive topline clinical trial data for UTI panel
December, 2022
OpGen to prepare FDA de novo request, completes clinical trial for UTI panel
December, 2022
Molecular diagnostics in treating lower respiratory tract infections with consideration for antimicrobial resistance
November, 2022
OpGen, FIND Ink R&D Collaboration for Rapid Detection of AMR via Blood Culture
September, 2022
FIND, Curetis Ink R&D Collaboration Agreement
September, 2022
Intelligent Genome Sequencing for Improved Infectious Disease Surveillance
August, 2022
Molecular Diagnostics: A Trusted Option for Hospitalized Patient Care
August, 2022
The panel combatting the rise of antibiotic resistance in UTIs
August, 2022
Hospitalized Pneumonia Panel Detects Infection Far Earlier Than Culture
August, 2022
OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial
June, 2022
Ares, Sandoz Extend Collaboration on Antimicrobial Resistance Surveillance, Treatment
May, 2022
Novartis Augments Transformational Week with US Approval, European Milestones
April, 2022
Novartis’ Sandoz Unit Extends Collaboration For Digital Solutions to Fight Antimicrobial Resistance
April, 2022
Sandoz And Ares Extend AMR Collaboration Ahead Of Next Phase
April, 2022
Novartis’ Sandoz, Ares Genetics seek better antibiotics deployment
April, 2022
Sandoz, Ares extend digital alliance on antimicrobial resistance
April, 2022
In Brief This Week: Cardea Bio, Proof Diagnostics, Ginkgo Bioworks, Twist Bioscience, More
April, 2022
OpGen Looks to Ramp up Clinical Use of Acuitas AMR Gene Panel in Wake of FDA Clearance
February, 2022
How The Diagnostic Community Can Integrate AI Into AMR
March, 2022
The future of combatting antimicrobial resistance
November, 2021
Antimicrobial Resistance (AMR): Best practices for antibiotic stewardship & infection control in long-term care
November, 2021
Antimicrobial Resistance (AMR): Precision Medicine & the Rise of Superbugs
October, 2021
Superbugs Could Be the Next Pandemic: We Need a Global, Comprehensive Plan to Address Them Now!
October, 2021
Ares Genetics ARESCloud
October, 2021
Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live, More
October, 2021
News Scan for Oct 04, 2021
October, 2021
OpGen receives clearance for AMR test panel
October, 2021
OpGen Receives FDA Clearance for Acuitas
®
AMR Gene Panel
October, 2021
Rockville medtech company OpGen just got FDA approval for its gene testing product
October, 2021
OpGen Receives FDA Clearance for AMR Panel, Prelim Q3 Revenues Up 9 Percent
October, 2021
Rockville biotech lands federal approval for superbug testing system
October, 2021
OpGen’s multiplex diagnostic panel found to reduce inappropriate antibiotic use
September, 2021
This is how to avoid a global superbug pandemic
September, 2021
Improving our approach to fighting AMR
August, 2021
Drug-Resistant Fungal ‘Superbug’ Has Health Officials Worried
July, 2021
OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum
June, 2021
F130 How Can We Optimize the Use of Antibiotics? (Oliver Schacht, OpGen)
April, 2021
In Brief This Week: OpGen, Sema4, PerkinElmer, Becton Dickinson, and More
April, 2021
PSQH: The Podcast Episode 25 – COVID-19 and Antibiotic Resistance
March, 2021
How Can Artificial Intelligence Stop the Spread of Antimicrobial Resistance?
March, 2021
Rapid testing can cut patient waiting time from days to hours
March, 2021
IBM Watson: Why Is Healthcare AI So Tough?
March, 2021
The state of bioinformatics in the fight against AMR
January, 2021
Trendspotting: Top Diagnostics Issues In 2021
January, 2021
Multiplex PCR Panel Provides Faster, Accurate Lower Respiratory Tract Infection Diagnosis
December, 2020
Cloud-Based Informatics Enable Smarter Antibiotic Use and Infection Control
December, 2020
Multiplex PCR Panels for Joint Infections on the Horizon
November, 2020
Q&A: Using faster diagnostics to treat COVID-19 patients
November, 2020
Battling Bacterial Antibiotic Resistance with OpGen’s Dr. Oliver Schacht
September, 2020
OpGen CEO Oliver Schacht Appears on Infection Control Today
September, 2020
Beware the super spreaders
September, 2020
Product News: OpGen Announces CE-IVD marking and launch of molecular diagnostic SARS-CoV-2 Kit
August, 2020
OpGen Earns CE Mark for COVID-19 Diagnostic
August, 2020
Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap
August, 2020
LRT panel provides specificity similar to traditional cultures with faster turnaround time
July, 2020
Lack of rapid diagnostic tools contributes to Covid-19 deaths
June, 2020
Understanding the role of technology in outbreak management: Lessons learned from COVID-19 and more
June, 2020
Facing antibiotic-resistant “Superbugs” in the fight against COVID19
June, 2020
State, private partners extend superbug fight (paywall)
June, 2020
OpGen Expands Partnership With New York State Department of Health to Detect AMR Infections
June, 2020
Antibiotic resistant co-infections: A silent killer in COVID-19 patients
May, 2020
Using Broader Diagnostics To Detect Bacterial Co-Infections And Drug Resistance In COVID-19 Patients
May, 2020
The Need for Broader Testing of COVID-19 Patients
May, 2020
OpGen, Sweden’s Karolinska Institutet to Study Bacterial Co-Infections in COVID-19 Pneumonia Patients
April, 2020
COVID-19 Patients Need to be Tested for Bacteria and Fungi, Not Just the Coronavirus
April, 2020
Technology takes the top position in outbreak management
April, 2020
Uncovering bacterial co-infections in COVID-19 patients with broader diagnostics
April, 2020
OpGen Completes Business Combination with Curetis
April, 2020
OpGen Closes On Curetis Purchase
April, 2020
Applying New Diagnostic Technologies in Long-Term Care
January, 2020
Fighting Infections with Genomic Testing: Evan Jones of OpGen Describes Exciting New Technology
January, 2020
Why cloud-based data collaboration tech could defend against superbug outbreaks
December, 2019
The Missing Link in Fighting Antibiotic Resistance
December, 2019
New Technology Can Identify Bacteria’s Genetic Make-Up, Fight Drug Resistance
October, 2019
OpGen CEO Evan Jones Appears on Digital Trends Live to Discuss Antibiotic Resistance
September, 2019
Improving infection control with new diagnostic technologies
September, 2019
A new light on antibiotic resistance
September, 2019
Gaithersburg’s OpGen to combine with German molecular diagnostic company
September, 2019
OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests
August, 2019
The growing role of rapid diagnostics and digital health In long-term care
July, 2019
OpGen’s Acuitas
®
AMR Gene Panel shows potential for reducing total time to targeted therapy
June, 2019
On The Mend Episode 8
June, 2019
Diagnostic test allows outbreak testing to begin more quickly than current WGS
June, 2019
Immune to drugs: Antimicrobial resistance could kill 10 million a year
May, 2019
OpGen submits antibiotic resistance test to FDA
May, 2019
Resist This: New York State Department of Health, ILÚM, OpGen Partner to Fight Antimicrobial Resistance
May, 2019
Top stories in infectious disease: FDA rejects antibiotic to treat complicated UTIs, US measles cases highest since 1994
April, 2019
Stopping Infection Outbreaks in Their Tracks With Diagnostic Technology
April, 2019
Q&A: Preventing hospital outbreaks with surveillance technology
March, 2019
Boosting infection control with new diagnostics
March, 2019
OpGen’s Bet on Precision Antibiotics
February, 2019
Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives
January, 2019
Next-Gen Technologies Aim to Reform the Microbiology Lab, But Do They Pose Significant Threats to the Big Guys?
December, 2018
OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia
December, 2018
In Brief This Week: Precipio, OpGen, Genedrive, and Danaher
December, 2018
OpGen Completes Specimen Accrual and Testing in Acuitas
®
Clinical Verification Study
November, 2018
New York State Initiative Hopes to Stop the Spread of Super Bugs
October, 2018
Solving healthcare’s $20 billion superbug problem
October, 2018
DOH joins private partners to fight ‘superbugs’
October, 2018
Healthcare’s $20B “super” problem
October, 2018
OpGen Partners With NYS DOH, Merck Subsidiary for Antimicrobial Resistance Surveillance
September, 2018
OpGen signs deal with New York health department to research superbugs
September, 2018
OpGen signs deal with New York health department to research superbug
September, 2018
